1Pirmohamed, M, James, S, Meakin, S, Green, C, Scott, AK, Walley, TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329(7456): 15–9.
2Wu, T, Jen, M, Bottle, A, Molokhia, M, Aylin, P, Bell, D, et al. Ten-year trends in hospital admissions for adverse drug reactions in England 1999–2009. J R Soc Med 2010; 103(6): 239–50.
3Elliott, R, Camacho, E, Campbell, F, Jankovic, D, St James, MM, Kaltenthaler, E, et al. Prevalence and Economic Burden of Medication Errors in the NHS in England: Rapid Evidence Synthesis and Economic Analysis of the Prevalence and Burden of Medication Error in the UK. Policy Research Unit in Economic Evaluation of Health & Care Interventions, 2018 (http://www.eepru.org.uk/prevalence-and-economic-burden-of-medication-errors-in-the-nhs-in-england-2/).
6Dean, B, Barber, N, Schachter, M. What is a prescribing error? Qual Health Care 2000; 9(4): 232–7.
7Mekonnen, AB, McLachlan, AJ, Brien, JE. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open 2016; 6(2): e010003.
9Maidment, ID, Lelliott, P, Paton, C. Medication errors in mental healthcare: a systematic review. Qual Saf Health Care 2006; 15(6): 409–13.
10Brownlie, K, Schneider, C, Culliford, R, Fox, C, Boukouvalas, A, Willan, C, et al. Medication reconciliation by a pharmacy technician in a mental health assessment unit. Int J Clin Pharm 2014; 36(2): 303–9.
11National Institute for Health and Care Excellence. Medicines Optimisation: the Safe and Effective Use of Medicines to Enable the Best Possible Outcomes. NICE guideline NG5. NICE, 2015.
13Barnett, K, Mercer, SW, Norbury, M, Watt, G, Wyke, S, Guthrie, B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 2012; 380(9836): 37–43.
14Brett, J, Daniels, B, Karanges, EA, Buckley, NA, Schneider, C, Nassir, A, et al. Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study. Br J Clin Pharmacol 2017; 83(11): 2581–8.
15Scottish Government Model of Care Polypharmacy Working Group. Polypharmacy Guidance (2nd edn). Scottish Government, 2015.
16Viron, MJ, Stern, TA. The impact of serious mental illness on health and healthcare. Psychosomatics 2010; 51(6): 458–65.
17Taqi, A, Johnson, CF, Akram, G. Psychotropic Medications Discrepancies Between Community Mental Health Teams and General Practice. Thesis report, University of Strathclyde, 2014.
19World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). WHO, 2016.
20Morris, LM, Brown, C, Williamson, M, Wyatt, JC. The Scottish Emergency Care Summary – an evaluation of a national shared record system aiming to improve patient care: technology report. Inform Prim Care 2012; 20(1): 41–9.
21Stubbs, J, Haw, C, Taylor, D. Prescription errors in psychiatry – a multi-centre study. J Psychopharmacol 2006; 20(4): 553–61.
22Gisev, N, Bell, JS, Chen, TF. Interrater agreement and interrater reliability: key concepts, approaches, and applications. Res Social Admin Pharm 2013; 9(3): 330–8.
23Paton, C, McIntyre, S, Bhatti, SF, Shingleton-Smith, A, Gray, R, Gerrett, D, et al. Medicines reconciliation on admission to inpatient psychiatric care: findings from a UK quality improvement programme. Ther Adv Psychopharmacol 2011; 1(4): 101–10.
24Tam, VC, Knowles, SR, Cornish, PL, Fine, N, Marchesano, R, Etchells, EE. Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review. CMAJ 2005; 173(5): 510–5.
25Dixon-Woods, M, McNicol, S, Martin, G. Ten challenges in improving quality in healthcare: lessons from the Health Foundation's programme evaluations and relevant literature. BMJ Qual Saf 2012; 21(10): 876–84.
26D'Lima, D, Crawford, MJ, Darzi, A, Archer, S. Patient safety and quality of care in mental health: a world of its own? BJPsych Bull 2017; 41(5): 241–3.
27Persell, SD, Doctor, JN, Friedberg, MW, Meeker, D, Friesema, E, Cooper, A, et al. Behavioral interventions to reduce inappropriate antibiotic prescribing: a randomized pilot trial. BMC Infect Dis 2016; 16: 373.
28Stockdale, SE, Sherin, JE, Chan, JA, Hermann, RC. Barriers and strategies for improving communication between inpatient and outpatient mental health clinicians. BMJ Qual Saf 2011; 20(11): 941–6.
29Johnson, CF, Ali Nassr, O, Harpur, C, Kenicer, D, Thom, A, Akram, G. Benzodiazepine and z-hypnotic prescribing from acute psychiatric inpatient discharge to long-term care in the community. Pharm Pract 2018; 16(3): 1256.
30Sinnott, C, McHugh, S, Browne, J, Bradley, C. GPs’ perspectives on the management of patients with multimorbidity: systematic review and synthesis of qualitative research. BMJ Open 2013; 3(9): e003610.
31Johnson, CF, Williams, B, MacGillivray, SA, Dougall, NJ, Maxwell, M. ‘Doing the right thing’: factors influencing GP prescribing of antidepressants and prescribed doses. BMC Fam Pract 2017; 18(1): 72.
32Dell'osso, B, Lader, M. Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal. Eur Psychiatry 2013; 28(1): 7–20.
33Ashton, H. Adverse effects of prolonged benzodiazepine use. Adverse Drug React Bull 1986; 118: 440–3.
34Kripke, DF. Greater incidence of depression with hypnotic use than with placebo. BMC Psychiatry 2007; 7: 42.
35Otto, MW, Bruce, SE, Deckersbach, T. Benzodiazepine use, cognitive impairment, and cognitive-behavioral therapy for anxiety disorders: issues in the treatment of a patient in need. J Clin Psychiatry 2005; 66(Suppl 2): 34–8.
36Tiihonen, J, Mittendorfer-Rutz, E, Torniainen, M, Alexanderson, K, Tanskanen, A. Mortality and cumulative exposure to antipsychotics, antidepressants, and benzodiazepines in patients with schizophrenia: an observational follow-up study. Am J Psychiatry 2016; 173(6): 600–6.